P53 GENE REARRANGEMENTS IN CHRONIC MYELOCYTIC-LEUKEMIA

被引:9
作者
HERNANDEZ, A [1 ]
HERNANDEZ, P [1 ]
CORRAL, L [1 ]
MUNIZ, A [1 ]
ALAEZ, C [1 ]
ESPINOSA, E [1 ]
FERNANDEZ, O [1 ]
MARTINEZ, G [1 ]
机构
[1] HOSP CARLOS J FINLAY,HAVANA,CUBA
关键词
P53; GENE; CML; REARRANGEMENTS; DELETIONS;
D O I
10.1007/BF01695889
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We performed Southern-blot analysis of the p 53 gene in 41 consecutive patients with typical chronic myelocytic leukemia (CML). In two of them, we were able to study cells during both the chronic and the accelerated phases. Only one of the 29 chronic-phase samples had rearrangement of the p 53 gene, whereas three of the nine accelerated-phase samples and one of the five patients in blast crisis exhibited rearrangements. Gene deletion was observed in two patients, one in accelerated phase and the other in blast crisis. One patient with a nonrearranged p 53 gene in chronic phase showed rearrangement after progression to the accelerated phase. On the other hand, one patient in accelerated phase exhibited rearrangements which disappeared after reversion to chronic phase with successful treatment. Our findings support the opinion that alterations of the p53 gene may play an important role in CML evolution.
引用
收藏
页码:81 / 83
页数:3
相关论文
共 20 条
[1]   ALTERATIONS IN THE P53 GENE AND THE CLONAL EVOLUTION OF THE BLAST CRISIS OF CHRONIC MYELOCYTIC-LEUKEMIA [J].
AHUJA, H ;
BARELI, M ;
ADVANI, SH ;
BENCHIMOL, S ;
CLINE, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (17) :6783-6787
[2]   THE SPECTRUM OF MOLECULAR ALTERATIONS IN THE EVOLUTION OF CHRONIC MYELOCYTIC-LEUKEMIA [J].
AHUJA, H ;
BARELI, M ;
ARLIN, Z ;
ADVANI, S ;
ALLEN, SL ;
GOLDMAN, J ;
SNYDER, D ;
FOTI, A ;
CLINE, M .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) :2042-2047
[3]   CLINICAL CHARACTERISTICS OF THE BLAST PHASE OF CHRONIC GRANULOCYTIC-LEUKEMIA [J].
CANELLOS, GP .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1990, 4 (02) :359-367
[4]   DETECTION OF A COMMON FEATURE IN SEVERAL HUMAN-TUMOR CELL-LINES - A 53,000-DALTON PROTEIN - (SIMIAN-VIRUS 40 TUMOR ANTIGEN-ASSOCIATED HOST PROTEIN-PHOSPHOPROTEIN-MONOCLONAL ANTIBODY-IMMUNOPRECIPITATION) [J].
CRAWFORD, LV ;
PIM, DC ;
GURNEY, EG ;
GOODFELLOW, P ;
TAYLORPAPADIMITRIOU, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (01) :41-45
[5]   THE EVOLVING ROLE OF BONE-MARROW TRANSPLANTATION IN THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA [J].
DELAGE, R ;
RITZ, J ;
ANDERSON, KC .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1990, 4 (02) :369-388
[6]   ALTERATIONS OF THE P53 GENE ARE ASSOCIATED WITH THE PROGRESSION OF A HUMAN PROSTATE CARCINOMA [J].
EFFERT, PJ ;
NEUBAUER, A ;
WALTHER, PJ ;
LIU, ET .
JOURNAL OF UROLOGY, 1992, 147 (03) :789-793
[7]   MUTATIONS OF THE P53-GENE IN ACUTE MYELOID-LEUKEMIA [J].
FENAUX, P ;
PREUDHOMME, C ;
QUIQUANDON, I ;
JONVEAUX, P ;
LAI, JL ;
VANRUMBEKE, M ;
LOUCHEUXLEFEBVRE, MH ;
BAUTERS, F ;
BERGER, R ;
KERCKAERT, JP .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 80 (02) :178-183
[8]   THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION [J].
FINLAY, CA ;
HINDS, PW ;
LEVINE, AJ .
CELL, 1989, 57 (07) :1083-1093
[9]  
FOTI A, 1991, BLOOD, V77, P2441
[10]  
KELMAN Z, 1989, BLOOD, V74, P2318